Unknown

Dataset Information

0

Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation.


ABSTRACT: Background:Diagnosis and monitoring of localized prostate cancer requires discovery and validation of noninvasive biomarkers. Nuclear magnetic resonance (NMR)-based metabolomics of seminal plasma reportedly improves diagnostic accuracy, but requires validation in a high-risk clinical cohort. Materials and methods:Seminal plasma samples of 151 men being investigated for prostate cancer were analyzed with 1H-NMR spectroscopy. After adjustment for buffer (add-to-subtract) and endogenous enzyme influence on metabolites, metabolite profiling was performed with multivariate statistical analysis (principal components analysis, partial least squares) and targeted quantitation. Results:Seminal plasma metabolites best predicted low- and intermediate-risk prostate cancer with differences observed between these groups and benign samples. Lipids/lipoproteins dominated spectra of high grade samples with less metabolite contributions. Overall prostate cancer prediction using previously described metabolites was not validated. Conclusion:Metabolomics of seminal plasma in vitro may assist urologists with diagnosis and monitoring of either low or intermediate grade prostate cancer. Less clinical benefit may be observed for high-risk patients. Further investigation in active surveillance cohorts, and/or in combination with in vivo magnetic resonance spectroscopic imaging may further optimize localized prostate cancer outcomes.

SUBMITTER: Roberts MJ 

PROVIDER: S-EPMC5693471 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation.

Roberts Matthew J MJ   Richards Renee S RS   Chow Clement W K CWK   Buck Marion M   Yaxley John J   Lavin Martin F MF   Schirra Horst Joachim HJ   Gardiner Robert A RA  

Prostate international 20170323 4


<h4>Background</h4>Diagnosis and monitoring of localized prostate cancer requires discovery and validation of noninvasive biomarkers. Nuclear magnetic resonance (NMR)-based metabolomics of seminal plasma reportedly improves diagnostic accuracy, but requires validation in a high-risk clinical cohort.<h4>Materials and methods</h4>Seminal plasma samples of 151 men being investigated for prostate cancer were analyzed with <sup>1</sup>H-NMR spectroscopy. After adjustment for buffer (add-to-subtract)  ...[more]

Similar Datasets

| S-EPMC11371927 | biostudies-literature
| S-EPMC7540358 | biostudies-literature
| S-EPMC4405216 | biostudies-literature
| S-EPMC7355445 | biostudies-literature
| S-EPMC3744172 | biostudies-literature
| S-EPMC9947740 | biostudies-literature
| S-EPMC7838731 | biostudies-literature
| S-EPMC8356911 | biostudies-literature
| S-EPMC4609897 | biostudies-literature
| S-EPMC10506469 | biostudies-literature